BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 24906564)

  • 21. Patients with asthma have a higher risk of systemic lupus erythematosus: a systematic review and meta-analysis.
    Charoenngam N; Ponvilawan B; Wongtrakul W; Ungprasert P
    Clin Rheumatol; 2021 Feb; 40(2):529-536. PubMed ID: 32638252
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Heterogeneity of peripheral blood monocytes, endothelial dysfunction and subclinical atherosclerosis in patients with systemic lupus erythematosus.
    Mikołajczyk TP; Osmenda G; Batko B; Wilk G; Krezelok M; Skiba D; Sliwa T; Pryjma JR; Guzik TJ
    Lupus; 2016 Jan; 25(1):18-27. PubMed ID: 26251402
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Endothelial function and markers of endothelial activation in relation to cardiovascular disease in systemic lupus erythematosus.
    Svenungsson E; Cederholm A; Jensen-Urstad K; Fei GZ; de Faire U; Frostegård J
    Scand J Rheumatol; 2008; 37(5):352-9. PubMed ID: 18666029
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Subclinical atherosclerosis in systemic lupus erythematosus and antiphospholipid syndrome: focus on β2GPI-specific T cell response.
    Conti F; Spinelli FR; Alessandri C; Pacelli M; Ceccarelli F; Marocchi E; Montali A; Capozzi A; Buttari B; Profumo E; Sorice M; Arca M; Valesini G; Riganò R
    Arterioscler Thromb Vasc Biol; 2014 Mar; 34(3):661-8. PubMed ID: 24436371
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Angiopoietin-2, endothelial dysfunction and renal involvement in patients with systemic lupus erythematosus.
    El-Banawy HS; Gaber EW; Maharem DA; Matrawy KA
    J Nephrol; 2012; 25(4):541-50. PubMed ID: 21956768
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A controlled comparison of brachial artery flow mediated dilation (FMD) and digital pulse amplitude tonometry (PAT) in the assessment of endothelial function in systemic lupus erythematosus.
    Aizer J; Karlson EW; Chibnik LB; Costenbader KH; Post D; Liang MH; Gall V; Gerhard-Herman MD
    Lupus; 2009 Mar; 18(3):235-42. PubMed ID: 19213862
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High prevalence of subclinical cardiovascular abnormalities in patients with systemic lupus erythematosus in spite of a very low clinical damage index.
    Palmieri V; Migliaresi P; Orefice M; Lupo T; Di Minno MN; Valentini G; Celentano A
    Nutr Metab Cardiovasc Dis; 2009 May; 19(4):234-40. PubMed ID: 19157818
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lack of association between mean platelet volume and disease activity in systemic lupus erythematosus patients: a systematic review and meta-analysis.
    Zhao CN; Mao YM; Wang P; Guan SY; Sam NB; Li XM; Wang DG; Pan HF
    Rheumatol Int; 2018 Sep; 38(9):1635-1641. PubMed ID: 29845430
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Endothelial progenitor cell phenotype and function are impaired in childhood-onset systemic lupus erythematosus.
    Mohan S; Barsalou J; Bradley TJ; Slorach C; Reynolds JA; Hasni S; Thompson B; Ng L; Levy D; Silverman E; Kaplan MJ
    Arthritis Rheumatol; 2015 May; 67(8):2257-62. PubMed ID: 25891295
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Endothelial dysfunction in Iranian lupus patients.
    Ahmadi B; Bonakdar ZS; Hashemi SM; Sadrkabir SM; Karimifar M
    Rheumatol Int; 2011 Jan; 31(1):27-31. PubMed ID: 19855975
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum resistin levels in patients with rheumatoid arthritis and systemic lupus erythematosus: a meta-analysis.
    Huang Q; Tao SS; Zhang YJ; Zhang C; Li LJ; Zhao W; Zhao MQ; Li P; Pan HF; Mao C; Ye DQ
    Clin Rheumatol; 2015 Oct; 34(10):1713-20. PubMed ID: 25935455
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association between serum total antioxidant status and flow-mediated dilation in patients with systemic lupus erythematosus: an observational study.
    Sincer İ; Kurtoğlu E; Yılmaz Çoşkun F; Aktürk S; Vuruşkan E; Düzen İV; Saraçoğlu E; Aktürk E; Hidayet Ş
    Anatol J Cardiol; 2015 Nov; 15(11):913-8. PubMed ID: 25868041
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predictors of carotid atherosclerosis in systemic lupus erythematosus.
    Maksimowicz-McKinnon K; Magder LS; Petri M
    J Rheumatol; 2006 Dec; 33(12):2458-63. PubMed ID: 17014002
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The fact not to ignore: Mean blood pressure is the main predictor of increased arterial stiffness in patients with systemic rheumatic diseases.
    Čypienė A; Dadonienė J; Miltinienė D; Rinkūnienė E; Rugienė R; Stropuvienė S; Badarienė J; Laucevičius A
    Adv Med Sci; 2017 Sep; 62(2):223-229. PubMed ID: 28500898
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel cardiovascular risk factors and cardiac event predictors in female inactive systemic lupus erythematosus patients.
    Karadag O; Calguneri M; Atalar E; Yavuz B; Akdogan A; Kalyoncu U; Bilgen SA; Ozer N; Ertenli AI; Ovunc K; Kiraz S
    Clin Rheumatol; 2007 May; 26(5):695-9. PubMed ID: 16909327
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metabolic syndrome is associated with increased arterial stiffness and biomarkers of subclinical atherosclerosis in patients with systemic lupus erythematosus.
    Sabio JM; Vargas-Hitos J; Zamora-Pasadas M; Mediavilla JD; Navarrete N; Ramirez A; Hidalgo-Tenorio C; Jáimez L; Martín J; Jiménez-Alonso J;
    J Rheumatol; 2009 Oct; 36(10):2204-11. PubMed ID: 19723903
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Noninvasive Assessment of Endothelial Dysfunction in Egyptian Patients with Lupus Nephritis.
    Fayed A; Soliman A; El-Khasab SO; Hammad H; Magdy M; Abu-Sheaishaa MA; El Wahab HA; Hegazy MT
    Saudi J Kidney Dis Transpl; 2021; 32(3):671-679. PubMed ID: 35102908
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Type I interferons are associated with subclinical markers of cardiovascular disease in a cohort of systemic lupus erythematosus patients.
    Somers EC; Zhao W; Lewis EE; Wang L; Wing JJ; Sundaram B; Kazerooni EA; McCune WJ; Kaplan MJ
    PLoS One; 2012; 7(5):e37000. PubMed ID: 22606325
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The risk factors of avascular necrosis in patients with systemic lupus erythematosus: a meta-analysis.
    Zhu KK; Xu WD; Pan HF; Zhang M; Ni J; Ge FY; Ye DQ
    Inflammation; 2014 Oct; 37(5):1852-64. PubMed ID: 24862229
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Elevated Circulating Interleukin-17 Levels in Patients with Systemic Lupus Erythematosus: A Meta-analysis.
    Shen HH; Fan Y; Wang YN; Zhao CN; Zhang ZK; Pan HF; Wu GC
    Immunol Invest; 2020 Aug; 49(6):662-675. PubMed ID: 31847623
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.